Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript

Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 5, 2026

Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance

BRENTWOOD, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2026.

GlobeNewsWire • May 5, 2026

Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.04 per share a year ago.

Zacks Investment Research • May 5, 2026

AUNA vs. SGRY: Which Hospital Stock Looks More Attractive Now?

Auna S.A. gains from Peru growth, stabilizing Mexico and Colombia cash flow focus, while Surgery Partners faces earnings cuts and headwinds.

Zacks Investment Research • Apr 22, 2026

Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., April 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2026 results before the market opens on Tuesday, May 5, 2026, to be followed by a conference call at 8:30 a.m. (Eastern Time).

GlobeNewsWire • Apr 17, 2026

SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES

Surgery Partners reported AN Adjusted EBITDA decline of 4.2% in Q4 following projections for continued expanding margins -- Levi & Korsinsky, LLP investigates potential securities law violations NEW YORK, April 1, 2026 /PRNewswire/ -- Surgery Partners (NASDAQ: SGRY) investors lost money after the Company's Q4 2025 earnings revealed a significant gap between the adjusted figures management highlighted and the Company's GAAP financial results. Shareholders who suffered a loss are encouraged to submit their information here.

PRNewsWire • Apr 1, 2026

SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES

SURGERY PARTNERS (SGRY) GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES Levi & Korsinsky, LLP investigates whether Surgery Partners' forward guidance concealed known cost pressures and operational risks that later drove an earnings miss and guidance downgrade NEW YORK, March 18, 2026 /PRNewswire/ -- Surgery Partners (NASDAQ: SGRY) shareholders watched the stock drop sharply in early March 2026 after Q4 2025 results and FY 2026 outlook both fell short of expectations. Months earlier, CEO Eric Evans told investors on the Q4 2024 earnings call: "we continue to expect margin expansion in 2025 and beyond.

PRNewsWire • Mar 18, 2026

Surgery Partners, Inc. Names Lloyd Dean to Board of Directors

BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors.

GlobeNewsWire • Mar 12, 2026

Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript

Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript

Seeking Alpha • Mar 10, 2026

Ortelius Delivers Open Letter to Surgery Partners Stockholders

NEW YORK--(BUSINESS WIRE)--Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ: SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisors, L.P. (“Ortelius” or “we”) believes that Surgery Partners, Inc. (“Surgery” or the “Company”) has significant upside potential, based on its high-quality assets, favorable industry dynamics, and considerable free cash flow capabilities. However, we are deeply concerned by the Company's abysmal per.

Business Wire • Mar 10, 2026